Most Favored Nation pricing: what it means for policy, patients and pharma

US pharmaceutical prices are the highest in the world -- President Trump's Most Favoured Nation (MFN) policy is trying to change that. But what does MFN pricing mean in practice? And what are the global ripple effects on drug innovation and R&D?  Grace Hampson is joined by Neil Grubert and Amanda Cole to talk about the biggest developments in U.S drug pricing policy – and what it means for the rest of the world.   A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud — debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. New episodes drop every Tuesday.  If there’s a topic you’d like us to cover, feel free to share your ideas.